The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Protein Glycosylation in Cancer
Open accessAbstract
Neoplastic transformation results in a wide variety of cellular alterations that impact the growth, survival, and general behavior of affected tissue. Although genetic alterations underpin the development of neoplastic disease, epigenetic changes can exert an equally significant effect on neoplastic transformation. Among neoplasia-associated epigenetic alterations, changes in cellular glycosylation have recently received attention as a key component of neoplastic progression. Alterations in glycosylation appear to not only directly impact cell growth and survival but also facilitate tumor-induced immunomodulation and eventual metastasis. Many of these changes may support neoplastic progression, and unique alterations in tumor-associated glycosylation may also serve as a distinct feature of cancer cells and therefore provide novel diagnostic and even therapeutic targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
Piccart-Gebhart, M. J., Procter, M., Leyland-Jones, B., Goldhirsch, A., Untch, M., Smith, I., Gianni, L., Baselga, J., Bell, R., Jackisch, C., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052306 · Cited by 5,084
Genetic instabilities in human cancers
Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1998) · Nature · doi:10.1038/25292 · Cited by 4,168
Cell surface protein glycosylation in cancer
Christiansen, M. N., Chik, J., Lee, L., Anugraham, M., Abrahams, J. L., & Packer, N. H. (2014) · PROTEOMICS · doi:10.1002/pmic.201300387 · Cited by 518
Liu, Y.-C., Yen, H.-Y., Chen, C.-Y., Chen, C.-H., Cheng, P.-F., Juan, Y.-H., Chen, C.-H., Khoo, K.-H., Yu, C.-J., Yang, P.-C., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1107385108 · Cited by 424
Wahrenbrock, M., Borsig, L., Le, D., Varki, N., & Varki, A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318882 · Cited by 317
Involvement of a Non-Human Sialic Acid in Human Cancer
Samraj, A. N., Läubli, H., Varki, N., & Varki, A. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00033 · Cited by 196
Glycopeptides from the Surface of Control and Virus-Transformed Cells
Buck, C. A., Glick, M. C., & Warren, L. (1971) · Science · doi:10.1126/science.172.3979.169 · Cited by 178
The Cosmc connection to the Tn antigen in cancer
Ju, T., Aryal, R. P., Kudelka, M. R., Wang, Y., & Cummings, R. D. (2014) · Cancer Biomarkers · doi:10.3233/cbm-130375 · Cited by 153
Self-citationChen, L., Zhang, W., Fregien, N., & Pierce, M. (1998) · Oncogene · doi:10.1038/sj.onc.1202124 · Cited by 102
Flagged first, then by citations
Research works printed but not linked: 289
- 10.1038/nrc1649 · DOI
- 10.1038/5947 · DOI
- 10.1016/j.chembiol.2013.12.010 · DOI · Paper page
- 10.1098/rstb.2012.0013 · DOI
- 10.1016/S1054-3589(08)60961-8 · DOI
- 10.1161/01.RES.0000137876.28454.64 · DOI
- 10.1038/nri2417 · DOI
- 10.1038/nrm3383 · DOI
- 10.1023/A:1015535427597 · DOI
- 10.1046/j.1365-2141.2003.04295.x · DOI
- 10.1155/2012/307093 · DOI
- Morgan WT, 1953, Br. J. Exp. Pathol., 34, 94
- 10.1039/b907931a · DOI · Paper page
- 10.1016/j.sbi.2005.08.010 · DOI
- 10.1146/annurev.bi.60.070191.001353 · DOI
- 10.1016/j.cell.2006.08.019 · DOI
- de Waard A, 1976, J. Biol. Chem., 251, 7581, 10.1016/S0021-9258(17)32891-0 · DOI
- 10.1038/nmeth807 · DOI
- 10.1038/nrc1527 · DOI
- Arthur CM, Methods Mol. Biol., 1207, 2015
- 10.1074/mcp.M112.023614 · DOI
- 10.1021/pr300810f · DOI
- 10.1038/emboj.2013.79 · DOI · Paper page
- 10.1515/BC.2009.043 · DOI
- 10.1016/0006-291X(83)91490-0 · DOI
- 10.1007/s11064-013-0979-2 · DOI
- 10.1074/jbc.M110.140038 · DOI
- 10.1074/jbc.M113.463927 · DOI
- 10.1023/B:GLYC.0000043740.26062.2c · DOI
- 10.1126/science.1239951 · DOI
- 10.1126/science.1214115 · DOI
- 10.1146/annurev.cb.05.110189.002411 · DOI
- 10.1155/2010/148178 · DOI
- 10.1073/pnas.84.10.3194 · DOI
- 10.1091/mbc.9.2.291 · DOI
- 10.1016/j.molcel.2013.03.003 · DOI
- 10.4161/pri.27892 · DOI
- 10.1002/anie.201203912 · DOI
- 10.1194/jlr.R700002-JLR200 · DOI
- 10.1093/glycob/cwp066 · DOI
- 10.1016/S0070-2153(10)92004-8 · DOI · Paper page
- 10.1016/S0076-6879(10)80018-7 · DOI
- 10.1007/978-1-62703-465-4_10 · DOI
- 10.1021/pr400101t · DOI
- Spiro RG, 1969, J. Biol. Chem., 244, 602, 10.1016/S0021-9258(18)94398-X · DOI
- 10.1128/MCB.02085-07 · DOI
- 10.1146/annurev-biochem-060608-102511 · DOI · Paper page
- 10.1146/annurev-nutr-071812-161240 · DOI
- 10.1242/jcs.00246 · DOI
- 10.1371/journal.pone.0076399 · DOI
- 10.1038/ncomms1591 · DOI
- 10.1038/nrc3114 · DOI
- 10.1096/fasebj.2.15.2973423 · DOI
- 10.1042/BJ20111416 · DOI
- 10.3389/fonc.2014.00028 · DOI
- 10.1093/glycob/cwn071 · DOI · Paper page
- 10.1038/nrd1751 · DOI
- 10.2174/187152008783330860 · DOI
- 10.1081/CNV-100107741 · DOI
- 10.1111/j.1440-1746.1998.tb00699.x · DOI
- Ogawa J, 1996, Cancer Res., 56, 325
- 10.1002/(SICI)1097-0215(19990924)83:1<70::AID-IJC14>3.0.CO;2-K · DOI
- 10.1158/0008-5472.CAN-11-1139 · DOI
- 10.1053/gast.1996.v110.pm8613039 · DOI
- 10.1016/j.febslet.2004.11.037 · DOI
- 10.3109/10520294809106232 · DOI
- 10.1016/S0065-230X(08)60215-8 · DOI
- Warnock ML, 1988, Am. J. Pathol., 133, 30
- 10.1074/jbc.M412378200 · DOI
- Arthur CM, Methods Mol. Biol., 1207, 2015
- 10.1016/j.chembiol.2008.11.004 · DOI
- 10.1016/j.cbpa.2013.12.017 · DOI
- 10.1146/annurev-biochem-061809-152236 · DOI
- 10.1021/cb300076s · DOI
- 10.1002/ijc.25778 · DOI
- Marcus DM, 1989, J. Immunol., 143, 2929, 10.4049/jimmunol.143.9.2929 · DOI
- 10.1021/cb300399s · DOI
- 10.1016/j.jim.2012.08.016 · DOI
- 10.1126/science.1162484 · DOI
- 10.1038/nprot.2007.227 · DOI
- Itzkowitz SH, 1989, Cancer Res., 49, 197
- 10.1038/bjc.1994.114 · DOI
- 10.1002/1097-0142(19951101)76:9<1529::AID-CNCR2820760905>3.0.CO;2-G · DOI
- 10.1093/ajcp/77.6.692 · DOI
- 10.1002/1097-0142(19950415)75:8<2051::AID-CNCR2820750804>3.0.CO;2-4 · DOI
- Nakamori S, 1993, Cancer Res., 53, 3632
- 10.1016/0003-4975(94)00866-6 · DOI
- 10.1046/j.1440-1746.2001.02425.x · DOI
- Jorgensen T, 1995, Cancer Res., 55, 1817
- Yago K, 1993, Cancer Res., 53, 5559
- 10.1126/science.1701275 · DOI
- 10.1126/science.1701274 · DOI
- 10.1016/0092-8674(90)90444-J · DOI
- 10.1073/pnas.0906074106 · DOI
- 10.1073/pnas.261704098 · DOI · Paper page
- 10.1073/pnas.95.16.9325 · DOI · Paper page
- 10.1056/NEJM199104183241603 · DOI
- Biondi C, 2008, Immunologia, 27, 127
- 10.1016/S0022-5347(17)55275-1 · DOI
- 10.1155/2008/797629 · DOI
- 10.1016/j.ejso.2006.10.004 · DOI
- 10.1007/BF01542654 · DOI
- Ballehaninna UK, 2012, J. Gastrointest. Oncol., 3, 105
- 10.1172/JCI110380 · DOI
- 10.1074/jbc.M103554200 · DOI
- 10.1016/j.cca.2012.10.058 · DOI
- 10.1006/scbi.1998.0119 · DOI
- Duffy MJ, 2001, Clin. Chem., 47, 624, 10.1093/clinchem/47.4.624 · DOI
- 10.1258/0004563011901055 · DOI
- 10.1038/nrc2351 · DOI
- 10.1038/nrurol.2012.258 · DOI
- 10.1007/s13277-013-0904-y · DOI
- Moriya S, 2013, Anticancer Res., 33, 997
- 10.2169/internalmedicine.51.6536 · DOI
- 10.1158/0008-5472.CAN-07-6389 · DOI
- 10.1016/j.ctrv.2013.09.002 · DOI
- Cole LA, 2008, J. Reprod. Med., 53, 499
- 10.1023/A:1011379725811 · DOI
- 10.1038/nrc1251 · DOI
- 10.1002/anie.201002313 · DOI
- Ju T, 2013, Proteomics Clin. Appl., 7, 618, 10.1002/prca.201300024 · DOI
- 10.1089/hyb.1996.15.401 · DOI
- Hanisch FG, 1989, Biol. Chem., 370, 21
- 10.1177/0091270006293758 · DOI
- 10.1074/jbc.M112.339465 · DOI
- 10.3233/CBM-130377 · DOI
- 10.1073/pnas.0914634107 · DOI
- 10.1158/0008-5472.CAN-10-4102 · DOI
- 10.1158/0008-5472.CAN-07-2345 · DOI
- 10.1073/pnas.0901454106 · DOI
- 10.1002/hep.510280408 · DOI
- 10.1158/0008-5472.CAN-09-3911 · DOI
- 10.1369/jhc.2008.952283 · DOI
- 10.1038/nm1627 · DOI
- 10.1074/jbc.M511826200 · DOI
- 10.1073/pnas.1406619111 · DOI
- 10.1074/jbc.M112.371989 · DOI
- 10.1002/mc.22011 · DOI
- 10.18632/oncotarget.1815 · DOI
- 10.1158/0008-5472.CAN-13-0869 · DOI
- 10.1371/journal.pone.0094995 · DOI
- 10.1016/S0304-4165(99)00183-X · DOI
- 10.1177/154405910508400103 · DOI
- 10.1073/pnas.0407983102 · DOI
- Malagolini N, 1989, Cancer Res., 49, 6466
- 10.1172/JCI59087 · DOI
- 10.1007/s00018-009-0126-z · DOI
- 10.1083/jcb.201003055 · DOI
- 10.1016/j.gene.2005.10.018 · DOI
- 10.1172/JCI6926 · DOI · Paper page
- Shimodaira K, 1997, Cancer Res., 57, 5201
- 10.1007/s10549-004-3137-3 · DOI
- 10.1073/pnas.1208253109 · DOI
- 10.1007/BF00925741 · DOI
- Dennis JW, 1989, Oncogene, 4, 853
- 10.1083/jcb.130.2.383 · DOI
- Yamamoto H, 2000, Cancer Res., 60, 134
- 10.1074/jbc.M112.370064 · DOI
- 10.1038/284067a0 · DOI
- 10.1016/j.febslet.2005.12.089 · DOI
- 10.1074/jbc.272.14.9275 · DOI
- 10.1158/0008-5472.CAN-06-3023 · DOI
- 10.1074/jbc.M202493200 · DOI
- 10.1038/300274a0 · DOI
- 10.1074/jbc.M011100200 · DOI
- 10.1002/jcp.21260 · DOI
- Meuillet EJ, 1999, Cancer Res., 59, 234
- 10.1073/pnas.0909862107 · DOI
- 10.1073/pnas.1220425110 · DOI
- 10.1007/s00262-006-0274-z · DOI
- 10.1158/0008-5472.CAN-07-1035 · DOI
- 10.1189/jlb.1012520 · DOI
- Ogata S, 1992, Cancer Res., 52, 4741
- 10.1016/S1471-4906(02)02296-2 · DOI
- 10.1158/0008-5472.CAN-04-0336 · DOI
- 10.1038/nm.2103 · DOI · Paper page
- 10.1016/j.coi.2007.05.006 · DOI
- 10.1038/nchembio.1525 · DOI
- 10.1002/ijc.26498 · DOI
- 10.1158/0008-5472.CAN-12-2418 · DOI
- 10.1016/j.cell.2014.01.043 · DOI
- 10.1182/blood-2006-03-007153 · DOI
- 10.4049/jimmunol.180.5.3091 · DOI
- 10.1006/bbrc.2001.6064 · DOI
- 10.1091/mbc.E04-03-0236 · DOI
- 10.1371/journal.pone.0067029 · DOI
- 10.1016/S0002-9440(10)64959-0 · DOI
- Dennis JW, 1990, Cancer Res., 50, 1867
- 10.1038/73163 · DOI · Paper page
- 10.1073/pnas.92.19.8754 · DOI · Paper page
- Yamamoto H, 2001, Cancer Res., 61, 6822
- 10.1136/gut.46.3.359 · DOI
- 10.1016/0006-291X(92)91872-N · DOI
- 10.1093/emboj/18.6.1516 · DOI
- 10.4049/jimmunol.168.4.1813 · DOI
- 10.1002/(SICI)1097-0215(19980105)75:1<105::AID-IJC16>3.0.CO;2-F · DOI
- Lotan R, 1983, Cancer Res., 43, 2088
- 10.1023/B:GLYC.0000014084.01324.15 · DOI
- 10.1016/S0304-4165(02)00313-6 · DOI
- 10.1084/jem.20111665 · DOI
200 of 289 shown
Cited by
Sorted by citations
Antiviral Cyanometabolites—A Review
Mazur-Marzec, H., Cegłowska, M., Konkel, R., & Pyrć, K. (2021) · Biomolecules · doi:10.3390/biom11030474 · Cited by 64
Park, D., Xu, G., Barboza, M., Shah, I. M., Wong, M., Raybould, H., Mills, D. A., & Lebrilla, C. B. (2017) · Glycobiology · doi:10.1093/glycob/cwx041 · Cited by 41
Over forty years of bladder cancer glycobiology: Where do glycans stand facing precision oncology?
Azevedo, R., Peixoto, A., Gaiteiro, C., Fernandes, E., Neves, M., Lima, L., Santos, L. L., & Ferreira, J. A. (2017) · Oncotarget · doi:10.18632/oncotarget.19433 · Cited by 39
Ovotransferrin—Multifunctional protein: Structure, bioactivity, and industrial potential
Fijałkowski, P., Pryshchepa, O., van Eldik, R., & Pomastowski, P. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.144810 · Cited by 10
Metadata
- Authors
- Stowell, S. R., Ju, T., & Cummings, R. D.
- Affiliations
- Departments of 1Pathology and Laboratory Medicine and
- Emory University (US)
- Venue
- Annual Review of Pathology: Mechanisms of Disease
- Publisher
- Annual Reviews
- Published
- 2015-01-24
- Volume
- 10
- Issue
- 1
- Pages
- 473-510
- ISSN
- 1553-4006 (ISSN-L)
- 1553-4014
- PMC
- PMC4396820
- OpenAlex
- W2171521392
- Cited by
- 873
- References
- 9
- Citations by year
- 2026: 48 · 2025: 88 · 2024: 100 · 2023: 84 · 2022: 100 · 2021: 102 · 2020: 91 · 2019: 69 · 2018: 70 · 2017: 68 · 2016: 39 · 2015: 12
- FWCI
- 6.11
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Annual Review of Pathology Mechanisms of Disease (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Wellcome Trust
- Hemophilia of Georgia
- National Institutes of Health (DP5OD019892)
- National Blood Foundation
- National Heart, Lung, and Blood Institute (P01HL085607)
- National Cancer Institute (U01CA168930)
- National Institute of General Medical Sciences (R24GM098791, P41GM103694)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
- Physical Sciences › Chemistry › Organic Chemistry › Carbohydrate Chemistry and Synthesis
- Keywords
- protein glycosylation, cancer, oncogenic transformation, epigenetic modifications, tumor progression, tumor immunomodulation, metastasis, tumor-associated glycosylation, diagnostic biomarkers, therapeutic target
- MeSH terms
- Animals, Cell Transformation, Neoplastic, Glycosylation, Humans, Neoplasm Proteins, Neoplasms, Epigenesis, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review